These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2608660)

  • 21. Role of the hydrophobic face of amphipathic alpha-helical peptides in synthetic pulmonary surfactants.
    McLean LR; Lewis JE; Hagaman KA; Owen TJ; Matthews ER
    J Pharmacol Exp Ther; 1993 Aug; 266(2):551-6. PubMed ID: 8355190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation.
    Landon C; Meudal H; Boulanger N; Bulet P; Vovelle F
    Biopolymers; 2006 Feb; 81(2):92-103. PubMed ID: 16170803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action.
    Yang ST; Lee JY; Kim HJ; Eu YJ; Shin SY; Hahm KS; Kim JI
    FEBS J; 2006 Sep; 273(17):4040-54. PubMed ID: 16889633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of alpha-helices to the surface activities of proteins.
    Krebs KE; Phillips MC
    FEBS Lett; 1984 Oct; 175(2):263-6. PubMed ID: 6479345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservation of amphipathic conformations in multiple protein structural alignments.
    Pascarella S; Argos P
    Protein Eng; 1994 Feb; 7(2):185-93. PubMed ID: 8170922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical main-chain length for conformational conversion from 3(10)-helix to alpha-helix in polypeptides.
    Pavone V; Benedetti E; Di Blasio B; Pedone C; Santini A; Bavoso A; Toniolo C; Crisma M; Sartore L
    J Biomol Struct Dyn; 1990 Jun; 7(6):1321-31. PubMed ID: 2363848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helix variants of PYY3-36.
    Pedersen SL; Bhatia VK; Jurt S; Paulsson JF; Pedersen MH; Jorgensen R; Holst B; Stamou D; Vrang N; Zerbe O; Jensen KJ
    J Pept Sci; 2012 Sep; 18(9):579-87. PubMed ID: 22865741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charge distributions and amphipathicity of receptor-binding alpha-helices.
    Dohlman JG; De Loof H; Segrest JP
    Mol Immunol; 1990 Oct; 27(10):1009-20. PubMed ID: 2172803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of recurrent hydrophobic residues in catalysis of helix formation by T cell-presented peptides in the presence of lipid vesicles.
    Lu S; Reyes VE; Lew RA; Anderson J; Mole J; Humphreys RE; Ciardelli T
    J Immunol; 1990 Aug; 145(3):899-904. PubMed ID: 2373862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An amphipathic alpha-helix at a membrane interface: a structural study using a novel X-ray diffraction method.
    Hristova K; Wimley WC; Mishra VK; Anantharamiah GM; Segrest JP; White SH
    J Mol Biol; 1999 Jul; 290(1):99-117. PubMed ID: 10388560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling of an antigenic complex between a viral peptide and a class I major histocompatibility glycoprotein.
    Rognan D; Reddehase MJ; Koszinowski UH; Folkers G
    Proteins; 1992 May; 13(1):70-85. PubMed ID: 1594579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.
    Duguid JG; Li C; Shi M; Logan MJ; Alila H; Rolland A; Tomlinson E; Sparrow JT; Smith LC
    Biophys J; 1998 Jun; 74(6):2802-14. PubMed ID: 9635734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
    Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
    ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of stable helical bundles from a combinatorial library of amphipathic peptides.
    Boon CL; Frost D; Chakrabartty A
    Biopolymers; 2004; 76(3):244-57. PubMed ID: 15148684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary structures of lipid-associating peptides: a Fourier transform infrared study.
    Zhong Q; Clark-Lewis I; Cushley RJ
    Pept Res; 1994; 7(2):99-106. PubMed ID: 7516748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hydrophobic moment of the amphipathic helix of salmon calcitonin and biological potency.
    Epand RM; Seyler JK; Orlowski RC
    Eur J Biochem; 1986 Aug; 159(1):125-7. PubMed ID: 3743567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Resolution Structural Studies Elucidate Antiatherogenic and Anti-Inflammatory Properties of Peptides Designed to Mimic Amphipathic α-Helical Domains of Apolipoprotein A-I.
    Mishra VK; Anantharamaiah GM
    Nat Prod Commun; 2019 May; 14(5):. PubMed ID: 32864035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The helical hydrophobic moments and surface activities of serum apolipoproteins.
    Krebs KE; Phillips MC
    Biochim Biophys Acta; 1983 Nov; 754(2):227-30. PubMed ID: 6652103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides.
    Scheller A; Wiesner B; Melzig M; Bienert M; Oehlke J
    Eur J Biochem; 2000 Oct; 267(19):6043-50. PubMed ID: 10998065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of lysine residue in amphipathic helical peptides on targeted delivery of RNA into cancer cells.
    Wada SI; Taniguchi K; Hamazaki H; Yamada A; Hayashi J; Uchiyama K; Urata H
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1934-1937. PubMed ID: 31133532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.